1. Introduction {#sec1}
===============

Glomus tumors are relatively rare soft tissue tumors composed of cells that resemble the modified smooth muscle cells of the specialized form of arteriovenous anastomosis "glomus body" [@bib1], [@bib2], [@bib3], [@bib4]. The most common site of the tumor is the subungual region; however, they occasionally occur in visceral organs such as airway tracts [@bib1], [@bib2]. Primary glomus tumors of the lung are exceedingly rare, and the diagnostic and therapeutic strategies for this rare condition have not been well established. Here, we report a case of primary pulmonary glomus tumor that arose in a left segmental bronchus as a protruding polypoid mass with a clinical manifestation of obstructive pneumonia. In the present case, bronchoscopic intervention became a powerful tool not only for histological diagnosis but also for determining the proper operative procedure for the tumor. Ever since the criteria for the diagnosis of malignancy in glomus tumors was first established in 2001 [@bib5], the malignancy estimation of visceral glomus tumors is a worrisome problem to be addressed because of the rarity of this condition. Recently, the criteria were modified and employed in the WHO classification of soft tissue and bone tumors 4th edition [@bib4]. However, pulmonary glomus tumors diagnosed by the current WHO criteria have been scarcely reported. We also reviewed previous cases of primary bronchopulmonary glomus tumors in the literature, with special attention given to current diagnostic criteria.

2. Case presentation {#sec2}
====================

A 38-year old woman visited a local hospital with the chief complaint of high fever and was diagnosed with pneumonia. She had no history of smoking. She had a past medical history of bronchial asthma, but asthmatic symptoms had ceased for a long time. Although antibiotic treatment was properly initiated, her symptoms persisted. Chest CT examination revealed a left lower lobe atelectasis with a water density mass in the left bronchus ([Fig. 1](#fig1){ref-type="fig"}a). Bronchoscopic examination revealed a polypoid mass in the left main bronchus. She was suspected of having a primary bronchial tumor and was referred to our hospital for further examination. Physical examination revealed decreased air entry in the left lower lung. Routine hematological and chemical laboratory results were normal, except for a slight increase in CRP (1.0 mg/dl). Upon initial bronchoscopic examination, a polypoid tumor was observed that occluded nearly 90% of the lumen of the left main bronchus ([Fig. 1](#fig1){ref-type="fig"}b). For confirmation of the tumor type, a partial resection of the tumor was performed by bronchoscopic snaring. Postoperative chest X-ray revealed improvement of the atelectasis, and she was tentatively discharged. The partially resected surgical specimen consisted of tumor tissue that measured 1.5 cm in diameter ([Fig. 1](#fig1){ref-type="fig"}c). The tumor was well-circumscribed, firm, and tan in color ([Fig. 1](#fig1){ref-type="fig"}d). Microscopically, the tumor was located within the bronchial interstitial connective tissue covered by the bronchial epithelium with focal erosion. The tumor was composed of sheets of oval to cuboidal cells. Abundant vascular spaces were observed in the tumor, and some were surrounded by tumor cells ([Fig. 2](#fig2){ref-type="fig"}a). Blood vessels in the tumor were small to medium-sized, thin-walled, and some were dilated, resembling capillaries or venules. The tumor cells were uniformly monotonous with a centrally placed round nucleus and amphophilic to lightly eosinophilic cytoplasm ([Fig. 2](#fig2){ref-type="fig"}b). No necrosis, vascular invasion, obvious cellular atypia, or mitotic figures were observed. Immunohistochemically, the tumor cells exhibited cytoplasmic positivity for α-smooth muscle actin, calponin, and vimentin ([Fig. 2](#fig2){ref-type="fig"}c and d). Immunostaining was negative for desmin. The individual tumor cells were surrounded by positive staining for silver impregnation and anti-type IV collagen antibody, which showed an intricate chicken-wire pattern representing basement membrane material ([Fig. 2](#fig2){ref-type="fig"}e and f). No immunoreactivity was found for cytokeratin, CD34, CD31, S-100, CD56, chromogranin A, or synaptophysin (data not shown). Ki-67 immunolabeling was detected in approximately 3% of tumor cell nuclei. Histopathologically, the tumor was diagnosed as a classical glomus tumor. Two weeks later, she was re-admitted to our hospital because of total collapse of the left lung. A repeat bronchoscopic examination revealed total obstruction of the left main bronchus with bloody and fibrinous coagulation. After removal of the coagulative materials with biopsy forceps, the bronchial tumor was resected by a snaring procedure. Then, the origin of the tumor was confined to the bronchial mucosa of the left lower lobe superior segmental bronchus. One month later, she underwent a left lower lobe superior segmental resection. Grossly, the tumor was a firm cylindrical mass measuring 2.6 cm in length and 1.4 cm in diameter, which arose from the superior segmental B^6a/b^ crista and filled and enlarged the lumen of B^6^, B^6a^, and B^6b^ ([Fig. 1](#fig1){ref-type="fig"}e--g). The proximal resection margin of the superior segmental bronchus was free of tumor. Histopathological examination of the resected specimen confirmed the preoperative diagnosis of a classical glomus tumor. In all sections, no necrosis, infiltrative growth, vascular invasion, conspicuous cellular atypia, increased mitotic activity, or atypical mitotic figures were observed. The patient had an uneventful postoperative course. She had no respiratory complaints and no recurrence of the tumor two years following tumor resection, and then she was lost to follow-up.

3. Discussion {#sec3}
=============

Glomus tumors are distinctive mesenchymal neoplasms composed of cells that closely resemble the normal glomus body [@bib1], [@bib2], [@bib3], [@bib4]. Glomus tumors are uncommon, with an estimated incidence of 1.6% in 500 consecutive soft tissue tumors [@bib6]. The vast majority of glomus tumors occur in the dermis and subcutis of the extremities, with the single most common site of the subungual region of the finger; however, rare tumors have been reported in visceral organs [@bib1], [@bib2]. Primary glomus tumors of the lung are exceedingly rare, with only 36 previously reported cases in the English literature ([Table 1](#tbl1){ref-type="table"}) [@bib5], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib22], [@bib23], [@bib24], [@bib25], [@bib26], [@bib27], [@bib28], [@bib29], [@bib30], [@bib31], [@bib32], [@bib33], [@bib34], [@bib35], [@bib36]. Almost the same number of cases with primary tracheal glomus tumors have also been reported to date [@bib37]. A survey of the literature shows that the primary bronchopulmonary glomus tumor usually occurred in adults, with the exception of a 9-year old female patient [@bib5]. There is an obvious male predominance (26 out of 37), in sharp contrast with a striking female predominance (male to female ratio of 1:3) among patients with subungual lesions [@bib1], [@bib2]. No causative relationship has yet been reported between smoking and tumorigenesis of glomus tumors. Primary pulmonary glomus tumors affected both bronchi and peripheral lung tissues including subpleural regions. In the bronchus, the tumor appeared as protruding polypoid masses, whereas it appeared as nodular lesions in the peripheral lung. The sizes of pulmonary glomus tumors tend to be larger than those of cutaneous glomus tumors with a typical tumor size of \<1 cm [@bib3], [@bib4]. Symptoms due to airway irritation and/or obstruction are common in bronchial glomus tumors, whereas peripherally arising glomus tumors are usually asymptomatic and found incidentally. The present case is a central (bronchial) type of glomus tumor of the lung presenting as pneumonia due to airway obstruction.

Histopathologically, there are two major diagnostic problems of primary pulmonary glomus tumors: first, the differential diagnosis of glomus tumors from other pulmonary tumors, and the second is the estimation of the malignant potential of this quite rare clinicopathological condition. In general, the items of differential diagnosis of cutaneal glomus tumors include adnexal tumors (especially hidradenoma) and less frequently intradermal nevi [@bib1], [@bib2]. In the rare condition of bronchopulmonary glomus tumors, however, the most important differential diagnosis would be a carcinoid tumor from the viewpoint of pathologists. A considerable number of primary pulmonary glomus tumors were initially misdiagnosed as carcinoid tumors based on the preoperative biopsy or intraoperative frozen section examinations [@bib10], [@bib12], [@bib18], [@bib21], [@bib27], [@bib28]. Carcinoid tumors bear some clinical, radiological, and histopathological similarities to glomus tumors [@bib15]. On the basis of radiological findings alone, they are difficult to distinguish because both of them appear as a well-delineated round mass by contrast enhancement [@bib16]. Histologically, uniformly monotonous tumor cells having bland round nuclei are common features of both, but the appearance of tumor cell nuclei is different between the two tumor entities. Glomus tumors lack the characteristic salt and pepper appearance of nuclear chromatin distribution typical for carcinoid tumors. Although both glomus tumors and carcinoid tumors are rich in blood vessels, it is important to note the differences in vasculature between these tumors. In carcinoid tumors, capillaries within delicate fibrous septa separate each tumor cell nest showing an organoid arrangement typical to neuroendocrine tumors; conversely, glomus tumor cells are constituents of neoplastic vascular walls resembling a normal glomus body. Immunohistochemically, positivity for cytoplasmic smooth muscle markers and pericellular basement membrane constituents is a reliable marker for glomus tumors. Neuroendocrine markers are always positive in carcinoid tumors, whereas they are negative in glomus tumors. Thus, immunohistochemical examination definitively differentiates these two entities, and recognition of the aforementioned cytological and vascular structural features is the most important point for planning an immunohistochemical evaluation.

Estimation of the malignant potential of bronchopulmonary glomus tumors is the other problem to be addressed. Indeed, most glomus tumors are benign and can be treated adequately by simple excision. However, glomus tumors showing histological atypia have been recognized, and furthermore, fatal cases with distant metastases are occasionally reported, comprising less than 1% of all glomus tumors [@bib3]. For primary bronchopulmonary glomus tumors, 10 cases with malignancy have been previously reported [@bib5], [@bib10], [@bib13], [@bib26], [@bib30], [@bib32], [@bib33], [@bib35], [@bib36]. Criteria for the diagnosis of malignancy in glomus tumors was proposed by Folpe et al. for the first time in 2001 [@bib5]. The criteria were introduced in a textbook of soft tissue tumors by Enzinger and Weiss [@bib1] and employed in the WHO classification of soft tissue and bone tumors, 3rd edition [@bib3]. In the criteria, the diagnosis of "malignant glomus tumor" should be reserved for tumors showing the following: 1) large size (\>2 cm) and deep location; 2) atypical mitotic figures; or 3) marked atypia with mitotic activity. According to the criteria, the majority of visceral glomus tumors could be diagnosed as "malignant" because of their consistent "deep" location and relatively large sizes. In the literature, however, 10 out of 19 cases of bronchopulmonary glomus tumors with sizes of \>2.0 cm did not show histologically atypical features or clinically malignant behavior. Because the first criterion was elaborated mainly based on a large number of atypical glomus tumors of the skin, whether this criterion was applicable to visceral glomus tumors remained uncertain [@bib14]. Currently, growing evidence has shown that most of the large and deeply located glomus tumors behave in a clinically benign fashion; therefore, the first diagnostic criterion was modified, and these lesions are now considered glomus tumors of uncertain malignant potential [@bib2], [@bib4]. Previous and current diagnostic criteria of glomus tumors with atypical features proposed by Folpe et al. are comparatively shown in [Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"}. Briefly, glomus tumors of \>2 cm in size with a deep location were previously diagnosed as malignant but are now categorized as having uncertain malignant potential. Visceral glomus tumors are essentially considered bearing uncertain malignant potential because of their deep location. However, malignancies are defined solely by histological findings in the current criteria. In our case, the tumor is 2.6 cm in maximal diameter, but neither mitotic figures nor an obvious nuclear atypia was observed. Our case is therefore defined as a glomus tumor of uncertain malignant potential, according to the current diagnostic criteria [@bib2], [@bib4]. The tumor grew cylindrically in the bronchial lumen with no infiltrative growth. There was no necrosis. Ki-67 immunolabeling was found in only approximately 3% of tumor cells. All of these findings suggested the probable benign nature of the tumor. A conservative surgery was therefore considered feasible. Our repeated bronchoscopic intervention allowed us to identify the origin of the tumor, thus opening a door for limited resection. Without the repeated interventions, the patient would have required at least a lobectomy. To date, the follow-up of glomus tumors of uncertain malignant potential has been good, but the number of cases is small and the follow-up period is short. Because it is still unclear whether large visceral glomus tumors are truly benign or potentially malignant indolent tumors, close postoperative follow-up is warranted.
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![Radiological, endoscopic, and macroscopic findings. (a) Contrast-enhanced chest CT reveals a water density mass in the left main bronchus (arrows). (b) Bronchoscopy shows a white polypoid mass filling the left main bronchial lumen. (c, d) The tip of the endobronchial tumor partially resected by endoscopic snaring procedure. The surface of the tumor is smooth, and the cut-surface is tan in color. (e--g) Formalin-fixed bronchopulmonary tissue obtained by left lower lobe segmental resection. A cylindrical mass arises from the superior segmental B^6a/b^ crista and enlarged the lumen of B^6^, B^6a^, and B^6b^.](gr1){#fig1}

![Histological and immunohistochemical findings. (a) The tumor was composed of sheets of oval to cuboidal cells. Numerous vascular spaces are observed in the tumor. Characteristically, tumor cells are constituents of the neoplastic vascular walls. H&E stain, original magnification x200. (b) The tumor cells are bland and uniformly monotonous with a centrally placed round nucleus. There are no chromatin increment, obvious nucleoli, or mitotic figures. H&E stain, original magnification x400. (c) The tumor cells are strongly immunoreactive for anti-α-smooth muscle actin antibody. Original magnification x200. (d) A portion of tumor cells are also immunoreactive for anti-calponin antibody. Original magnification x200. (e) The individual tumor cell is surrounded by positive immunostaining for anti-type IV collagen antibody. Original magnification x400. (f) Silver impregnation shows an intricate chicken-wire pattern between tumor cells, representing basement membrane material. Original magnification x400.](gr2){#fig2}

###### 

Summary of reported cases of primary bronchopulmonary glomus tumors.

Table 1

  Ref.       Age/sex      Presenting symptoms          Side   Location                   Size (cm)   Biopsy diagnosis             Postoperative histological diagnosis     Metastasis; site                              Treatment                                     Clinical outcome          Classification according to the WHO 3rd/4th ed.
  ---------- ------------ ---------------------------- ------ -------------------------- ----------- ---------------------------- ---------------------------------------- --------------------------------------------- --------------------------------------------- ------------------------- -------------------------------------------------
  [@bib7]    67/M         Epigastralgia                L      Lower lobe, subpleural     6.5         N/A                          GT                                       No                                            Lobectomy                                     FOD at 9 months           MGT/GTUMP
  [@bib8]    34/M         ASX                          R      Upper lobe                 2.0         N/A                          GT                                       No                                            Lobectomy                                     N/A                       GTUMP/GTUMP
  [@bib9]    50/M         ASX                          R      Subpleural                 1.1         Not performed                GT                                       No                                            Wedge resection                               N/A                       GTUMP/GTUMP
  [@bib9]    41/M         ASX                          R      Lower lobe, peripheral     1.5         Not performed                GT                                       No                                            Wedge resection                               FOD at 47 months          GTUMP/GTUMP
  [@bib10]   20/M         Pneumothorax                 L      Main bronchus              1.4         Carcinoid                    GT                                       No                                            Sleeve resection                              FOD at 9 months           GTUMP/GTUMP
  [@bib10]   65/F         ASX                          R      Infrahilar                 3.0         Not performed                GT                                       No                                            Wedge resection                               FOD at 60 months          MGT/GTUMP
  [@bib10]   40/M         ASX                          R      Lower lobe, subpleural     1.1         Hemangiopericytoma           GT                                       No                                            Lobectomy                                     FOD at 6 months           GTUMP/GTUMP
  [@bib10]   69/M         Hemoptysis                   R      Upper lobe                 9.5         Not performed                Glomangiosarcoma                         Lung, Mediastinum, Brain, Liver, Skin         Lobectomy; chemotherapy                       DOD at 17 months          MGT/MGT
  [@bib5]    38/M         N/A                          N/A    Lung                       3.8         N/A                          Glomangiosarcoma                         N/A                                           N/A                                           N/A                       MGT/MGT
  [@bib5]    9/F          N/A                          N/A    Lung                       4.5         N/A                          Glomangiosarcoma                         GI tract                                      N/A                                           AWD at 60 months          MGTMGT
  [@bib11]   48/M         Hemosputum                   L      Main bronchus              0.7         GT                           GT                                       No                                            Wedge resection                               FOD at 3 months           GTUMP/GTUMP
  [@bib12]   29/F         Cough, dyspnea, chest pain   L      Main bronchus              1.5         Carcinoid tumor              GT                                       No                                            Bronchotomy plus mass extirpation             FOD at 17 months          GTUMP/GTUMP
  [@bib13]   53/M         Cough                        R      Basal bronchus             2.5         Degenerated atypical cells   Glomangiosarcoma                         No                                            Lobectomy                                     FOD at 23 months          MGT/MGT
  [@bib14]   29/M         Chest discomfort             R      Main bronchus              3.0         Adenoma                      GT of undetermined malignant potential   No                                            Sleeve upper lobectomy with node dissection   N/A                       MGT/GTUMP
  [@bib15]   40/M         Fever, cough, chest pain     R      Main bronchus              0.9         Not performed                GT                                       No                                            Endoscopic removal                            FOD at 1 month            GTUMP/GTUMP
  [@bib16]   50/M         ASX                          R      Upper lobe                 4.0         N/A                          GT                                       No                                            Lobectomy                                     N/A                       MGT/GTUMP
  [@bib17]   37/M         Cough                        R      Bronchus intermedius       N/A         GT                           Not obtained                             No                                            Laser coagulation followed by cryotherapy     FOD at 3 months           N/D
  [@bib18]   67/M         Cough                        R      Superior bronchial trunk   0.8         Typical carcinoid            GT                                       No                                            Segmental resection                           N/A                       GTUMP/GTUMP
  [@bib19]   64/M         ASX                          L      Lower lobe                 3.5         Not performed                Glomangioma                              No                                            Tumor removal                                 N/A                       MGT/GTUMP
  [@bib20]   56/F         Hemoptysis                   R      Lower lobe                 5.5         Not diagnostic               Glomangiomyoma                           No                                            Lobectomy                                     N/A                       MGT/GTUMP
  [@bib21]   34/M         Cough                        R      Bronchus intermedius       2.3         Typical carcinoid            GT                                       No                                            Sleeve resection                              N/A                       MGT/GTUMP
  [@bib22]   55/M         ASX                          R      Upper lobe                 1.1         N/A                          GT                                       No                                            Lobectomy                                     N/A                       GTUMP/GTUMP
  [@bib23]   69/M         Hemoptysis                   R      Main bronchus              2.0         Angiomatous lesion           GT                                       No                                            N/A                                           N/A                       GTUMP/GTUMP
  [@bib24]   21/F         ASX                          L      Upper lobe, parahilar      2.5         N/A                          GT                                       No                                            Lobectomy                                     N/A                       MGT/GTUMP
  [@bib25]   39/M         Cough                        L      Main bronchus              2.5         GT                           GT                                       No                                            Endoscopic resection                          FOD at 72 months          MGT/GTUMP
  [@bib26]   74/M         Cough, dyspnea, chest pain   R      Upper lobe, parahilar      3.4         GT                           Glomangiosarcoma                         No                                            Lobectomy with node dissection                FOD at 12 months          MGT/MGT
  [@bib27]   late 30s/M   Hemosputum                   R      Bronchus intermedius       1.5         Carcinoid, suspected         GT                                       No                                            Sleeve lobectomy                              FOD at 10 months          GTUMP/GTUMP
  [@bib28]   39/M         ASX                          L      Upper lobe                 N/A         Neuroendocrine tumor         Glomangioma                              No                                            Lobectomy with node dissection                FOD at 51 months          N/D
  [@bib29]   62/M         Hemoptysis                   L      Main bronchus              1.6         GT                           GT                                       No                                            Sleeve lobectomy                              FOD at 30 months          GTUMP/GTUMP
  [@bib30]   35/F         Hemoptysis                   L      Hilum                      N/A         Glomangiosarcoma             Glomangiosarcoma                         Lymph node, Lung                              Pneumonectomy with node dissection            N/A                       MGT/MGT
  [@bib31]   43/F         ASX                          R      Upper lobe, peripheral     2.0         Sclerosing hemangioma        GT                                       No                                            Thoracoscopic lung resection                  FOD at 6 months           GTUMP/GTUMP
  [@bib32]   28/M         Hyperpyrexia, anemia         R      Upper lobe                 3.0         Not performed                Low-grade MGT                            No                                            Lobectomy                                     FOD at 12 months          MGT/Suspicion of GTUMP
  [@bib33]   60/F         Cough, hemoptysis            L      Upper lobe, parahilar      2.5         MGT                          Not obtained                             Lymph node, GI tract, Spleen, Adrenal gland   Not performed                                 DOD within a few months   MGT/MGT
  [@bib34]   49/M         Cough, dyspnea, chest pain   R      Lower lobe                 3.0         Not performed                GTUMP                                    No                                            Wedge resection                               N/A                       MGT/GTUMP
  [@bib35]   59/F         Cough, hemoptysis            L&R    Multiple                   2.5         MGT                          Not obtained                             Lymph node, Lung, GI tract, Spleen            Not performed                                 DOD within 20 weeks       MGT/MGT
  [@bib36]   66/F         ASX                          R      Middle lobe                4.5         Not performed                MGT                                      No                                            Lobectomy                                     FOD at 13 months          MGT/Suspicion of GTUMP
  \*         38/F         Fever                        L      Lower lobe, B^6^           2.6         GT                           GTUMP                                    No                                            Segmentectomy                                 FOD at 24 months          MGT/GTUMP

AWD, alive with disease; ASX, asymptomatic; DOD, died of disease, DOOD, died of other disease; F, female; FOD, free of disease; GI, gastrointestinal; GT, glomus tumor; GTUMP, glomus tumor of uncertain malignant potential; L, left; M, male; MGT, malignant glomus tumor; N/A, not available; N/D, not determinable because of undetailed histological information; R, right; \*, our case.

###### 

WHO classification of glomus tumors with atypical features.

Table 2

  WHO 3rd edition (2002)                                                                                                                       WHO 4th edition (2013)
  -------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------
  *Malignant glomus tumors*                                                                                                                    
  1)Size \>2 cm and subfascial or visceral location or2)Marked nuclear atypia and any level of mitotic activity or3)Atypical mitotic figures   1)Marked nuclear atypia and any level of mitotic activity or2)Atypical mitotic figures
  *Glomus tumors of uncertain malignant potential*                                                                                             
  Not fulfilling criteria for malignancy, but having at least one atypical feature other than nuclear pleomorphism                             Not fulfilling criteria for malignancy, but having at least one atypical feature other than nuclear pleomorphism
  *Symplastic glomus tumors*                                                                                                                   
  Striking nuclear atypia in the absence of any other worrisome feature (e.g., large size, deep location, mitotic activity, necrosis)          Striking nuclear atypia in the absence of any other features indicative of negative outcome (e.g., large size, deep location, mitotic activity, necrosis)

###### 

Classification of glomus tumors with atypical features in *Enzinger and Weiss\'s Soft Tissue Tumors*.

Table 3

  5th edition (2008)                                                                                                      6th edition (2014)
  ----------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------
  *Malignant glomus tumors*                                                                                               
  1)Marked atypia + mitotic activity (5 \> 50 HPF) or2)Atypical mitotic figures or3)Large size (\>2 cm) + deep location   1)Marked atypia + mitotic activity (5 \> 50 HPF) or2)Atypical mitotic figures
  *Glomus tumors of uncertain malignant potential*                                                                        
  1)Superficial location + high mitotic activity (\>5/50 HPF) or2)Large size only or3)Deep location only                  1)Superficial location + mitotic activity (5 \> 50 HPF) or2)Large size (\>2 cm) and/or deep location
  *Symplastic glomus tumors*                                                                                              
  Lacks criteria for malignant glomus tumor and marked nuclear atypia only                                                Lacks criteria for malignant glomus tumor and marked nuclear atypia only
